Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.82
Delayed Data
As of Jul 22
 -1.66 / -6.78%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
AssetsCash958.0M1.4B597.3M1.3B
 
 
 
 
 
Short Term Investment Cash-903.5M409.6M-779.8M713.1M
 
 
 
 
 
Cash & Short Term Investments958.0M1.4B613.3M1.3B
 
 
 
 
 
 
ReceivablesReceivables2.4B2.7B2.7B2.7B
 
 
 
 
 
 
InventoriesInventories1.2B1.2B1.3B1.3B
 
 
 
 
 
 
Current AssetsPrepaid Expenses----20.0M--
 
 
Other Current Assets1.8B1.7B930.4M894.4M
 
 
 
 
 
Current Assets6.3B7.0B5.5B6.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.4B1.4B2.6B--
 
 
 
 
Depreciation-----1.2B--
 
 
Intangible Assets40.4B39.8B41.6B40.9B
 
 
 
 
 
Other Assets40.5B40.0B41.9B41.2B
 
 
 
 
 
Total Assets48.3B48.5B49.0B49.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable415.8M476.8M433.7M438.1M
 
 
 
 
 
Short Term Debt590.9M707.0M838.5M675.1M
 
 
 
 
 
Accrued Expenses3.1B3.3B692.1M3.3B
 
 
 
 
 
Other Current Liabilities3.2B3.5B3.6B3.5B
 
 
 
 
 
Other Liabilities4.3B4.7B5.3B4.6B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.3B30.2B30.3B31.3B
 
 
 
 
 
Deferred Taxes-6.1B-5.9B-5.7B-5.7B
 
 
 
 
 
Other Liabilities723.2M809.3M1.1B1.1B
 
 
 
 
 
Total Liabilities41.8B42.0B42.9B43.2B
 
 
 
 
 
 
EquityMinority Interest-1.4M-2.2M-500.0K-800.0K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity6.4B6.3B5.9B5.7B
 
 
 
 
 
Total Shareholder Equity6.4B6.3B5.9B5.7B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding342.8M343.1M342.9M343.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.